We tested if introducing by transgenesis a tagged human RPGRIP1L protein under the control of the col2a1a (Dale and Topczewski, 2011) or foxj1a (Van Gennip et al., 2018) enhancers (Figure 1H) would reduce scoliosis penetrance and severity. The gene discussed is RPGRIP1L; the disease is scoliosis.